Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1a/1b Open Label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of DBC-664 in Adult Patients With Locally Advanced or Metastatic Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07705035
Title field or adapter rule
{'original_value': 'A Phase 1a/1b Open Label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of DBC-664 in Adult Patients With Locally Advanced or Metastatic Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:31.104159+00:00
Published At
2026-10-27T00:00:00+00:00
Record Updated At
2026-10-27
Source Retrieved At
2026-10-31T22:18:28.651351+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Malignant Germ Cell Tumor", "Lung Adenocarcinoma", "Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma", "Urothelial Carcinoma", "Endometrial Adenocarcinoma", "Ovarian Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-27", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07705035"
protocolSection.identificationModule.officialTitle
"A Phase 1a/1b Open Label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of DBC-664 in Adult Patients With Locally Advanced or Metastatic Solid Tumors"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Malignant Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Endometrial Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Adenocarcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Part 1 (Dose Escalation)', 'Part 2 (Dose Expansion)'], 'description': 'DBC-664 will be administered intravenously.', 'name': 'DBC-664', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.